Improving gene therapy for breathing problems in Duchenne muscular dystrophy
Optimizing Gene Therapy for Respiratory Insufficiency in Duchenne Muscular Dystrophy
This study is looking at a new gene therapy to help improve breathing and muscle health for people with Duchenne muscular dystrophy (DMD) by using a special virus to deliver a helpful gene, and it's being tested in mouse models that mimic human conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10980431 on NIH RePORTER |
What this research studies
This research focuses on Duchenne muscular dystrophy (DMD), a severe genetic disorder that leads to muscle degeneration and respiratory failure. The team aims to optimize gene therapy using adeno-associated viruses (AAV) to deliver a microdystrophin gene, which is crucial for muscle function, particularly in respiratory muscles. By studying humanized mouse models, the researchers will assess how well this therapy can improve breathing and overall muscle health, potentially leading to better treatment options for patients with DMD.
Who could benefit from this research
Good fit: Ideal candidates for this research are young children diagnosed with Duchenne muscular dystrophy, particularly those experiencing respiratory insufficiency.
Not a fit: Patients with other forms of muscular dystrophy or those who are not experiencing respiratory issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality of life and survival rates for patients with Duchenne muscular dystrophy by improving respiratory function.
How similar studies have performed: Previous studies using AAV-based gene therapies have shown promising results in improving muscle function, indicating potential success for this approach in treating DMD.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Elmallah, Mai — Duke University
- Study coordinator: Elmallah, Mai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.